Mark Bachleda
Board Member
Lyell Immunopharma, Inc. (LYEL)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Mark Bachleda
Mark Bachleda is recorded as Board Member at Lyell Immunopharma, Inc. (LYEL). Lyell Immunopharma, Inc. reported in an 8-K filed June 9, 2025 that Mark Bachleda was appointed Class I director, effective June 9, 2025.
“On June 9, 2025, the Board of Directors (the "Board") of Lyell Immunopharma, Inc. (the "Company") increased the authorized size of the Board from seven directors to eight directors and, upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Mark Bachleda, Pharm.D., M.B.A., to the Board as a Class I director.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-06-09–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Lyell Immunopharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Lynn Seely CEO, Board Member
- Cathy Friedman Chairman
- Lynn Seely, M.D. CFO
- Smital Shah CFO
- Stephen Hill COO
- Richard Goold CIO
- Mark Meltz General Counsel
- Veronica Sanchez Bulis Chief Accounting Officer
- Catherine Friedman Board Member
- Elizabeth Nabel Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.